Početna › Ateroskleroza › North Carolina
Kliničke studije za Ateroskleroza u državi North Carolina
12 studija za Ateroskleroza traži sudionike na lokacijama u državi North Carolina.
Gradovi u državi North Carolina
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- UNC Heart & Vascular, Chapel Hill
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Care Access - Fayetteville, Fayetteville
- Medication Management, Greensboro
- Monroe Biomedical Research, Monroe
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07157774Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 100 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT01143480Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Novant Health Heart and Vascular Institute, Charlotte
- Velocity Clinical Research - Durham, Durham
- Moses H Cone Memorial Hospital, Greensboro
- i još 7
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- NC Heart and Vascular Research, LLC, Raleigh
- Javara Inc. - Wake Forest University Health Sciences, Winston-Salem
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Metrolina Nephrology Associates, PA, Charlotte
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
- i još 3
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Asheville
- Research Site, Chapel Hill
- Research Site, Charlotte
- i još 11
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Wake Forest University Baptist Medical Center, Winston-Salem
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06813911Pelacarsen Roll-over Extension Program
- Monroe Biomedical Research, Monroe
- Alliance Medical Ministry, Raleigh
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06875973Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
U tijeku regrutacija
Od 40 do 75 godina · Oba spola · Ažurirano 13. tra 2026. · NCT06568601Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
U tijeku regrutacijaFaza 2
Od 40 do 75 godina · Oba spola · Ažurirano 27. velj 2026. · NCT06488105Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Durham VA Medical Center, Durham, NC, Durham
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT02915198Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.